Annual CFF
$3.15 M
+$238.36 M+101.34%
31 December 2023
Summary:
TherapeuticsMD annual cash flow from financing activities is currently $3.15 million, with the most recent change of +$238.36 million (+101.34%) on 31 December 2023. During the last 3 years, it has fallen by -$77.57 million (-96.10%). TXMD annual CFF is now -98.33% below its all-time high of $188.83 million, reached on 31 December 2019.TXMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
30 September 2024
Summary:
TherapeuticsMD quarterly cash flow from financing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has increased by +$1000.00 (+100.00%). TXMD quarterly CFF is now -100.00% below its all-time high of $136.96 million, reached on 31 March 2016.TXMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.00 M
+$1000.00+0.05%
30 September 2024
Summary:
TherapeuticsMD TTM cash flow from financing activities is currently $2.00 million, with the most recent change of +$1000.00 (+0.05%) on 30 September 2024. Over the past year, it has increased by +$112.80 million (+101.81%). TXMD TTM CFF is now -99.16% below its all-time high of $237.55 million, reached on 31 March 2020.TXMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.3% | +100.0% | +101.8% |
| 3 y3 years | -96.1% | -100.0% | -98.8% |
| 5 y5 years | -98.1% | -100.0% | -98.2% |
TXMD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.6% | +101.3% | -100.0% | +100.0% | -98.8% | +100.8% |
| 5 y | 5 years | -98.3% | +101.3% | -100.0% | +100.0% | -99.2% | +100.8% |
| alltime | all time | -98.3% | +101.3% | -100.0% | +100.0% | -99.2% | +100.8% |
TherapeuticsMD Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $2.00 M(+0.0%) |
| June 2024 | - | $0.00(-100.0%) | $2.00 M(-36.5%) |
| Dec 2023 | $3.15 M(-101.3%) | $2.00 M(<-9900.0%) | $3.15 M(-102.8%) |
| Sept 2023 | - | -$1000.00(-100.1%) | -$110.80 M(+1.6%) |
| June 2023 | - | $1.15 M(-101.0%) | -$109.06 M(-53.6%) |
| Dec 2022 | -$235.21 M(-281.6%) | -$111.94 M(-6537.3%) | -$235.21 M(+92.9%) |
| Sept 2022 | - | $1.74 M(-101.4%) | -$121.91 M(+32.8%) |
| June 2022 | - | -$120.00 M(+2300.0%) | -$91.83 M(-421.0%) |
| Mar 2022 | - | -$5.00 M(-469.5%) | $28.60 M(-77.9%) |
| Dec 2021 | $129.55 M(+60.5%) | $1.35 M(-95.7%) | $129.55 M(-19.0%) |
| Sept 2021 | - | $31.82 M(+7335.0%) | $159.90 M(+24.7%) |
| June 2021 | - | $428.00 K(-99.6%) | $128.19 M(+0.3%) |
| Mar 2021 | - | $95.95 M(+202.6%) | $127.85 M(+58.4%) |
| Dec 2020 | $80.72 M(-57.2%) | $31.70 M(>+9900.0%) | $80.72 M(-36.0%) |
| Sept 2020 | - | $106.00 K(+12.8%) | $126.05 M(+0.1%) |
| June 2020 | - | $94.00 K(-99.8%) | $125.96 M(-47.0%) |
| Mar 2020 | - | $48.82 M(-36.6%) | $237.55 M(+25.8%) |
| Dec 2019 | $188.83 M(+16.0%) | $77.03 M(>+9900.0%) | $188.83 M(+68.3%) |
| Sept 2019 | - | $8500.00(-100.0%) | $112.23 M(-44.5%) |
| June 2019 | - | $111.69 M(>+9900.0%) | $202.23 M(+24.2%) |
| Mar 2019 | - | $100.10 K(-76.7%) | $162.84 M(+0.0%) |
| Dec 2018 | $162.79 M(+124.3%) | $429.90 K(-99.5%) | $162.79 M(+0.3%) |
| Sept 2018 | - | $90.02 M(+24.5%) | $162.36 M(+15.2%) |
| June 2018 | - | $72.30 M(>+9900.0%) | $140.91 M(+101.4%) |
| Mar 2018 | - | $44.10 K(>+9900.0%) | $69.98 M(-3.6%) |
| Dec 2017 | $72.58 M(-47.1%) | $0.00(-100.0%) | $72.58 M(-0.0%) |
| Sept 2017 | - | $68.57 M(+4945.8%) | $72.59 M(+1704.8%) |
| June 2017 | - | $1.36 M(-48.8%) | $4.02 M(+37.8%) |
| Mar 2017 | - | $2.65 M(>+9900.0%) | $2.92 M(-97.9%) |
| Dec 2016 | $137.23 M(+47.6%) | $10.00 K(+900.0%) | $137.23 M(-0.5%) |
| Sept 2016 | - | $1000.00(-99.6%) | $137.86 M(-19.0%) |
| June 2016 | - | $254.60 K(-99.8%) | $170.21 M(-0.1%) |
| Mar 2016 | - | $136.96 M(>+9900.0%) | $170.45 M(+83.3%) |
| Dec 2015 | $92.97 M(+114.7%) | $642.80 K(-98.0%) | $92.97 M(+0.7%) |
| Sept 2015 | - | $32.36 M(+6480.3%) | $92.36 M(-10.2%) |
| June 2015 | - | $491.70 K(-99.2%) | $102.90 M(+0.2%) |
| Mar 2015 | - | $59.48 M(>+9900.0%) | $102.74 M(+137.3%) |
| Dec 2014 | $43.30 M(-41.5%) | $30.20 K(-99.9%) | $43.30 M(+0.8%) |
| Sept 2014 | - | $42.89 M(>+9900.0%) | $42.96 M(+40.7%) |
| June 2014 | - | $334.20 K(+733.4%) | $30.54 M(-8.0%) |
| Mar 2014 | - | $40.10 K(-112.9%) | $33.19 M(-55.1%) |
| Dec 2013 | $73.99 M(+412.5%) | -$309.90 K(-101.0%) | $73.99 M(-7.3%) |
| Sept 2013 | - | $30.47 M(+919.8%) | $79.82 M(+55.6%) |
| June 2013 | - | $2.99 M(-92.7%) | $51.30 M(-2.7%) |
| Mar 2013 | - | $40.84 M(+639.7%) | $52.71 M(+265.1%) |
| Dec 2012 | $14.44 M(+206.7%) | $5.52 M(+183.1%) | $14.44 M(+34.0%) |
| Sept 2012 | - | $1.95 M(-55.7%) | $10.77 M(+5.9%) |
| June 2012 | - | $4.40 M(+71.5%) | $10.17 M(+47.3%) |
| Mar 2012 | - | $2.57 M(+38.2%) | $6.91 M(+46.7%) |
| Dec 2011 | $4.71 M(+48.5%) | $1.86 M(+37.7%) | $4.71 M(-28.4%) |
| Sept 2011 | - | $1.35 M(+18.5%) | $6.57 M(+50.2%) |
| June 2011 | - | $1.14 M(+209.7%) | $4.38 M(+31.1%) |
| Mar 2011 | - | $367.20 K(-90.1%) | $3.34 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $3.17 M(+143.8%) | $3.72 M(-537.7%) | $3.17 M(-1368.2%) |
| Sept 2010 | - | -$850.00 K(-950.0%) | -$250.00 K(-115.6%) |
| June 2010 | - | $100.00 K(-50.0%) | $1.60 M(+6.7%) |
| Mar 2010 | - | $200.00 K(-33.3%) | $1.50 M(+15.4%) |
| Dec 2009 | $1.30 M(-688.0%) | $300.00 K(-70.0%) | $1.30 M(+30.0%) |
| Sept 2009 | - | $1.00 M(>+9900.0%) | $1.00 M(>+9900.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2009 | - | $0.00(0.0%) | -$181.40 K(-18.0%) |
| Dec 2008 | -$221.20 K(-76.6%) | $0.00(0.0%) | -$221.20 K(-81.0%) |
| Sept 2008 | - | $0.00(-100.0%) | -$1.17 M(0.0%) |
| June 2008 | - | -$181.40 K(+355.8%) | -$1.17 M(+18.4%) |
| Mar 2008 | - | -$39.80 K(-95.8%) | -$983.70 K(+4.2%) |
| Dec 2007 | -$943.90 K(+214.0%) | -$943.90 K(<-9900.0%) | -$943.90 K(<-9900.0%) |
| Sept 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2006 | -$300.60 K(-200.0%) | $0.00(0.0%) | -$300.60 K(<-9900.0%) |
| Sept 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2006 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2006 | - | -$300.60 K(-200.0%) | $0.00(-100.0%) |
| Dec 2005 | $300.60 K(>+9900.0%) | $300.60 K(>+9900.0%) | $300.60 K(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2004 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2004 | - | $0.00(0.0%) | -$10.60 K(+1666.7%) |
| June 2004 | - | $0.00(0.0%) | -$600.00(-113.6%) |
| Mar 2004 | - | $0.00(-100.0%) | $4400.00(-56.0%) |
| Dec 2003 | $10.00 K(-66.7%) | -$10.60 K(-206.0%) | $10.00 K(-80.2%) |
| Sept 2003 | - | $10.00 K(+100.0%) | $50.60 K(+24.6%) |
| June 2003 | - | $5000.00(-10.7%) | $40.60 K(+14.0%) |
| Mar 2003 | - | $5600.00(-81.3%) | $35.60 K(+18.7%) |
| Dec 2002 | $30.00 K(<-9900.0%) | $30.00 K(>+9900.0%) | $30.00 K(>+9900.0%) |
| Sept 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2001 | -$200.00(+100.0%) | $0.00(0.0%) | -$200.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) | -$200.00(-33.3%) |
| June 2001 | - | $0.00(-100.0%) | -$300.00(0.0%) |
| Mar 2001 | - | -$200.00(<-9900.0%) | -$300.00(+200.0%) |
| Dec 2000 | -$100.00(-99.3%) | $0.00(-100.0%) | -$100.00(-99.6%) |
| Sept 2000 | - | -$100.00(<-9900.0%) | -$23.70 K(-341.8%) |
| June 2000 | - | $0.00(0.0%) | $9800.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | $9800.00(-172.1%) |
| Dec 1999 | -$13.60 K(+1600.0%) | -$23.60 K(-170.7%) | -$13.60 K(-236.0%) |
| Sept 1999 | - | $33.40 K(>+9900.0%) | $10.00 K(-142.7%) |
| June 1999 | - | $0.00(-100.0%) | -$23.40 K(0.0%) |
| Mar 1999 | - | -$23.40 K | -$23.40 K |
| Dec 1998 | -$800.00(+166.7%) | - | - |
| Dec 1997 | -$300.00(-99.4%) | - | - |
| Dec 1996 | -$53.40 K(-232.8%) | - | - |
| Dec 1995 | $40.20 K(>+9900.0%) | - | - |
| Dec 1994 | $0.00(-100.0%) | - | - |
| Dec 1993 | -$100.00 | - | - |
FAQ
- What is TherapeuticsMD annual cash flow from financing activities?
- What is the all time high annual CFF for TherapeuticsMD?
- What is TherapeuticsMD annual CFF year-on-year change?
- What is TherapeuticsMD quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for TherapeuticsMD?
- What is TherapeuticsMD quarterly CFF year-on-year change?
- What is TherapeuticsMD TTM cash flow from financing activities?
- What is the all time high TTM CFF for TherapeuticsMD?
- What is TherapeuticsMD TTM CFF year-on-year change?
What is TherapeuticsMD annual cash flow from financing activities?
The current annual CFF of TXMD is $3.15 M
What is the all time high annual CFF for TherapeuticsMD?
TherapeuticsMD all-time high annual cash flow from financing activities is $188.83 M
What is TherapeuticsMD annual CFF year-on-year change?
Over the past year, TXMD annual cash flow from financing activities has changed by +$238.36 M (+101.34%)
What is TherapeuticsMD quarterly cash flow from financing activities?
The current quarterly CFF of TXMD is $0.00
What is the all time high quarterly CFF for TherapeuticsMD?
TherapeuticsMD all-time high quarterly cash flow from financing activities is $136.96 M
What is TherapeuticsMD quarterly CFF year-on-year change?
Over the past year, TXMD quarterly cash flow from financing activities has changed by +$1000.00 (+100.00%)
What is TherapeuticsMD TTM cash flow from financing activities?
The current TTM CFF of TXMD is $2.00 M
What is the all time high TTM CFF for TherapeuticsMD?
TherapeuticsMD all-time high TTM cash flow from financing activities is $237.55 M
What is TherapeuticsMD TTM CFF year-on-year change?
Over the past year, TXMD TTM cash flow from financing activities has changed by +$112.80 M (+101.81%)